Authority & regime
- Competent authority
- The Instituto de Salud Pública de Chile (ISP) is the competent authority for medical devices and IVDs ('elementos de uso médico'): it authorizes and supervises the control/certification of…

Research ISP/ANDIM registration records, classification, regulations, timelines, fees, and market updates — the stable entrance to every Chile medical device resource.
Check whether product features may trigger separate radio, electrical, metrology, radiation, import, or other Chile requirements.
Follow recent Instituto de Salud Pública de Chile — Agencia Nacional de Dispositivos Médicos (ISP/ANDIM) policy, guidance, safety, and compliance updates.
Read the official ISP general-device and IVD risk-classification guides with citeable Spanish passages.
Compare official and realistic ISP approval times by device class and pathway.
Describe your device and get a preliminary ISP risk class with official rule references.
Review current ISP application, review, and renewal fees.
24 of 25 research dimensions currently covered · 21 official sources · latest verification 2026-09-07
No source-verified answer is published for this dimension yet.
ISP/ANDIM registration fees in CLP · reviewed 2026-08-25
| Fee line | Amount | Provenance |
|---|---|---|
| Registration dossier review (item 9100002) | CLP 487,880 | Verified |
| Registration authorization (item 9100003) | CLP 165,628 | Verified |
| Company inscription (item 9100016) | CLP 311,935 | Verified |
| Registration modification (item 9100017) | CLP 69,321 | Verified |
Public Health Institute of Chile (ISP) review clocks and planning ranges · 4-class (I, II, III, IV) — D.S. 102/2014 classification
Official ISP/ANDIM rules and guidance · 2 of 2 documents linked to official sources
The target market is carried into each tool. Add the product, evidence, or regulatory change you want to assess.
Structure company, product, model, approval, certificate, and evidence facts before starting Chile work.
Connect the ISP/ANDIM route, evidence, labels, local role, timing, and dependencies to a wider launch plan.
Compare an existing authorization and evidence set against ISP/ANDIM administrative, testing, labeling, and dossier needs.
Map a product or manufacturing change to ISP/ANDIM evidence, notification, timing, and implementation questions.
Assess a current ISP/ANDIM update against one product and turn it into an owner-ready action workpaper.
Review connected-device architecture, risks, SBOM, testing, lifecycle controls, and market-specific questions for Chile (ISP/ANDIM).

